These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 3515696)

  • 21. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
    Belitsky P; MacDonald AS; Cohen AD; Crocker J; Hirsch D; Jindal K; Lawen J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):999-1000. PubMed ID: 1989359
    [No Abstract]   [Full Text] [Related]  

  • 22. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.
    Lloveras J; Puig JM; Comerma I; Orfila A; Mir M; Masramón J; Aubia J
    Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract]   [Full Text] [Related]  

  • 24. Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation.
    Mourad G; Legendre C; Argiles A; Bonardet A; Mion C
    Transplant Proc; 1987 Oct; 19(5):3672-3. PubMed ID: 3313886
    [No Abstract]   [Full Text] [Related]  

  • 25. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 26. A prospective study of conversion from cyclosporine to azathioprine: comparison of clinical and morphologic findings.
    Abbud-Filho M; Ramalho HJ; Barberato JB; Corrente JE; Salgueiro MC; Mazzetto MR; Bezas AG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):164-8. PubMed ID: 3291235
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract]   [Full Text] [Related]  

  • 28. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
    Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC
    Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
    [No Abstract]   [Full Text] [Related]  

  • 29. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract]   [Full Text] [Related]  

  • 30. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
    Lloveras J; Masramon J; Orfila A; Cuevas X; Aubia J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2027-8. PubMed ID: 2978888
    [No Abstract]   [Full Text] [Related]  

  • 31. New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation.
    Simmons RL; Canafax DM; Fryd DS; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):76-81. PubMed ID: 3008390
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporine alone or in combination with prednisone in cadaveric renal transplantation.
    Thiel G; Harder F; Loertscher R; Brünisholz M; Landmann J; Brunner F; Follat F; Wenk M; Mihatsch M
    Transplant Proc; 1984 Oct; 16(5):1187-90. PubMed ID: 6385374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
    Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
    First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial.
    Spielberger M; Aigner F; Schmid T; Bösmüller C; Königsrainer A; Margreiter R
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):169-70. PubMed ID: 3291236
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of cyclosporine with poor initial renal function results in severely diminished renal clearance up to three years following liver transplantation.
    Cooper JL; Wahlstrom E; Anderson J; Schwerman L; Poterucha J; Krom RA
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1489-91. PubMed ID: 1989274
    [No Abstract]   [Full Text] [Related]  

  • 38. The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.
    Smith AY; Van Buren CT; Lewis RM; Kerman RH; Welsh M; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):180-93. PubMed ID: 3291239
    [No Abstract]   [Full Text] [Related]  

  • 39. A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity.
    Salomon D; Brunson M; Vansickler J; Pfaff W; Howard R; Peterson J; Curry T; Thompson R; Squiers E
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1018-9. PubMed ID: 1989143
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.